To investigate the serum concentration of soluble Fas(sFas) in patients with Graves? disease(GD), serum sFas was determined by solid phase sandwich enzyme-linked immunosorbent assay(ELISA) in 58 patients with GD.

• 为探讨Graves病 (GD)患者血清可溶性凋亡相关蛋白Fas(sFas)的水平及临床意义 ,应用固相ELISA法检测了 5 8例GD患者和 2 2名正常对照组血清sFas含量。